Big Victory! Pharma Giant Bristol-Myers Squibb Bans Near-Drowning Test

Published by .
2 min read

Thanks to your hundreds of thousands of e-mails and PETA’s campaign, Bristol-Myers Squibb has confirmed to us that it has banned the forced swim test!

Gerbil Playing with Straw Ball

The resounding victory for small animals comes after more than a year of pressure that included nearly 800,000 e-mails from supporters, resolutions to ban the test from PETA and a compassionate shareholder, ads, videos, and public protests.

A 'Drowning Mouse' Protests Forced Swim Test

PETA launched the campaign after our scientists reviewed documents showing that between 2008 and 2017, Bristol-Myers Squibb employees published papers describing the use of more than 1,600 animals—748 gerbils, 698 mice, and 192 rats—in cruel and pointless forced swim tests. The animals were dropped into inescapable containers of water, and experimenters watched as they panicked and frantically searched for an escape. There were likely many more animals subjected to this atrocity in studies that weren’t published.

The experiment is often used to test human antidepressant medications, but it has been widely discredited. The 1,600-plus animals who thought they were drowning in Bristol-Myers Squibb’s laboratories over the last decade? Their suffering didn’t lead to even one new drug on the market.

So far, PETA and our supporters have persuaded 13 companies to stop or ban these near-drowning tests on small animals—including 10 Big Pharma corporations. And we can do it again. Send a quick e-mail to Eli Lilly and urge the company to join its competitors in banning the forced swim test today.

GET PETA UPDATES
Stay up to date on the latest vegan trends and get breaking animal rights news delivered straight to your inbox!

By submitting this form, you’re acknowledging that you have read and agree to our privacy policy and agree to receive e-mails from us.

Get the Latest Tips—Right in Your Inbox
We’ll e-mail you weekly with the latest in vegan recipes, fashion, and more!

By submitting this form, you’re acknowledging that you have read and agree to our privacy policy and agree to receive e-mails from us.